Issue: July 25, 2012
July 25, 2012
1 min read
Save

Physician joins advisory committee

Issue: July 25, 2012
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Timothy Cripe, MD, PhD

Timothy Cripe

Timothy Cripe, MD, PhD, recently was appointed to the Cellular, Tissue and Gene Therapy Advisory Committee.

The committee provides guidance to the FDA about novel cellular, tissue and gene therapy therapeutics and devices. The panel also reviews applications that involve cellular therapies, such as embryonic stem cells.

Cripe is chief of hematology, oncology and bone marrow transplantation at Nationwide Children’s Hospital in Columbus, Ohio. He previously served as medical co-director in clinical and translational research at Cincinnati Children’s Hospital Medical Center.

His clinical interests include gene and viral therapies for solid tumors in children, including brain tumors, neuroblastoma, and bone and soft tissue sarcomas.